Investigational Site Number :7560001

Zurich 8091

0 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Hemophilia A

Studies at this site

• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease — Running, not enrolling
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed